These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10743953)

  • 1. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 2: hydroxyindole derivatives.
    Milkiewicz KL; Marsilje TH; Woodworth RP; Bifulco N; Hangauer MJ; Hangauer DG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):483-6. PubMed ID: 10743953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives.
    Marsilje TH; Milkiewicz KL; Hangauer DG
    Bioorg Med Chem Lett; 2000 Mar; 10(5):477-81. PubMed ID: 10743952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.
    Guan H; Laird AD; Blake RA; Tang C; Liang C
    Bioorg Med Chem Lett; 2004 Jan; 14(1):187-90. PubMed ID: 14684325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pp60c-Src inhibitor PP1 is non-competitive against ATP.
    Karni R; Mizrachi S; Reiss-Sklan E; Gazit A; Livnah O; Levitzki A
    FEBS Lett; 2003 Feb; 537(1-3):47-52. PubMed ID: 12606029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR CoMFA study on oxindole derivatives as cyclin dependent kinase 1 (CDK1) and cyclin dependent kinase 2 (CDK2) inhibitors.
    Singh SK; Dessalew N; Bharatam PV
    Med Chem; 2007 Jan; 3(1):75-84. PubMed ID: 17266627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analogues.
    Sundaramoorthi R; Shakespeare WC; Keenan TP; Metcalf CA; Wang Y; Mani U; Taylor M; Liu S; Bohacek RS; Narula SS; Dalgarno DC; van Schravandijk MR; Violette SM; Liou S; Adams S; Ram MK; Keats JA; Weigle M; Sawyer TK; Weigele M
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3063-6. PubMed ID: 12941334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor scaffolds as new allele specific kinase substrates.
    Kraybill BC; Elkin LL; Blethrow JD; Morgan DO; Shokat KM
    J Am Chem Soc; 2002 Oct; 124(41):12118-28. PubMed ID: 12371851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel aminomethylindole derivatives as inhibitors of pp60c-Src tyrosine kinase: synthesis and biological activity.
    Işgör YG; Kiliç Z; Olgen S
    Chem Biol Drug Des; 2008 Dec; 72(6):599-604. PubMed ID: 19090928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular gate which controls unnatural ATP analogue recognition by the tyrosine kinase v-Src.
    Liu Y; Shah K; Yang F; Witucki L; Shokat KM
    Bioorg Med Chem; 1998 Aug; 6(8):1219-26. PubMed ID: 9784863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Biological, and Computational Evaluation of Novel 1,3,5-Substituted Indolin-2-one Derivatives as Inhibitors of Src Tyrosine Kinase.
    Kilic-Kurt Z; Bakar F; Ölgen S
    Arch Pharm (Weinheim); 2015 Oct; 348(10):715-29. PubMed ID: 26260414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
    Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of allele-specific inhibitors to probe protein kinase signaling.
    Bishop AC; Shah K; Liu Y; Witucki L; Kung C; Shokat KM
    Curr Biol; 1998 Feb; 8(5):257-66. PubMed ID: 9501066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseases.
    Wang Y; Metcalf CA; Shakespeare WC; Sundaramoorthi R; Keenan TP; Bohacek RS; van Schravendijk MR; Violette SM; Narula SS; Dalgarno DC; Haraldson C; Keats J; Liou S; Mani U; Pradeepan S; Ram M; Adams S; Weigele M; Sawyer TK
    Bioorg Med Chem Lett; 2003 Sep; 13(18):3067-70. PubMed ID: 12941335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent Inhibitors of c-Src Tyrosine Kinase That Bind a Regulatory Domain.
    Johnson TK; Soellner MB
    Bioconjug Chem; 2016 Jul; 27(7):1745-9. PubMed ID: 27266260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-Pyrrolidinyl- and 7-piperidinyl-5-aryl-pyrrolo[2,3-d]pyrimidines--potent inhibitors of the tyrosine kinase c-Src.
    Altmann E; Missbach M; Green J; Susa M; Wagenknecht HA; Widler L
    Bioorg Med Chem Lett; 2001 Mar; 11(6):853-6. PubMed ID: 11277536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl-indolyl maleimides as inhibitors of CaMKIIdelta. Part 1: SAR of the aryl region.
    Levy DE; Wang DX; Lu Q; Chen Z; Perumattam J; Xu YJ; Liclican A; Higaki J; Dong H; Laney M; Mavunkel B; Dugar S
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2390-4. PubMed ID: 18334294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.